DaVita (BSP:DVAI34) Interest Expense : R$-2,613 Mil (TTM As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is DaVita Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. DaVita's interest expense for the three months ended in Dec. 2024 was R$ -846 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was R$-2,613 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. DaVita's Operating Income for the three months ended in Dec. 2024 was R$ 2,933 Mil. DaVita's Interest Expense for the three months ended in Dec. 2024 was R$ -846 Mil. DaVita's Interest Coverage for the quarter that ended in Dec. 2024 was 3.47. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

DaVita Interest Expense Historical Data

The historical data trend for DaVita's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DaVita Interest Expense Chart

DaVita Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Expense

Get a 7-Day Free Trial

-1,564.56

-1,613.08

-1,872.71

-1,952.82

-2,870.33

DaVita Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Interest Expense	Get a 7-Day Free Trial															-471.31	-495.08	-526.48	-745.29	-846.34

DaVita Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was R$-2,613 Mil.

DaVita (BSP:DVAI34) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

DaVita's Interest Expense for the three months ended in Dec. 2024 was R$-846 Mil. Its Operating Income for the three months ended in Dec. 2024 was R$2,933 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was R$69,463 Mil.

DaVita's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2024 )	/	Interest Expense (Q: Dec. 2024 )
	=	-1	*	2932.922	/	-846.337
	=	3.47

The higher the ratio, the stronger the company's financial strength is.

DaVita Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DaVita Inc (BSP:DVAI34) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

DVA:USA 0I7E:UK TRL:Germany TRL:Germany

Address

2000 16th Street, Denver, CO, USA, 80202

Website

https://www.davita.com

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the us, and treats about 250,000 patients globally each year. Government payers dominate us dialysis reimbursement. DaVita receives about two thirds of us sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of the us patients treated, they represent nearly all of the profits generated by DaVita in the us dialysis business.

DaVita Headlines

No Headlines